ArticleTranslational lung cancer research2018

Temozolomide in combination with either veliparib or placebo in patients with relapsed-sensitive or refractory small-cell lung cancer.

Chiara Lazzari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.